• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯切除治疗小尺寸乳腺导管原位癌。

Excision alone for small size ductal carcinoma in situ of the breast.

作者信息

Kim Haeyoung, Noh Jae Myoung, Choi Doo Ho, Lee Jihye, Nam Seok Jin, Lee Jeong Eon, Park Won, Huh Seung Jae

机构信息

Department of Radiation Oncology, Hallym University Dongtan Sacred Heart Hospital, South Korea.

Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, South Korea.

出版信息

Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23.

DOI:10.1016/j.breast.2014.05.025
PMID:24969239
Abstract

This study was performed to determine the risk of tumor recurrence after local excision alone in patients with small size (≤1 cm) ductal carcinoma in situ (DCIS) of the breast. We have treated 107 patients who had DCIS measuring ≤1 cm with margin widths of ≥0.3 cm with excision alone per institutional protocol. With a median follow-up time of 58 months, 4 patients developed ipsilateral breast tumor recurrence (IBTR). Two of the 4 recurrences were invasive, whereas 2 were DCIS. The 5-year rate of IBTR was 6.1%. The patients with resection margin of <1.0 cm had significantly higher rate of IBTR than the patients with resection margin of ≥1.0 cm (23.1% vs. 1.5% at 5-year, p < 0.01). In conclusion, radiotherapy is necessary in the patients with resection margin of <1.0 cm after excision alone because of the substantial risk of IBTR.

摘要

本研究旨在确定乳腺小尺寸(≤1 cm)导管原位癌(DCIS)患者单纯局部切除术后肿瘤复发的风险。我们按照机构方案,对107例DCIS大小≤1 cm且切缘宽度≥0.3 cm的患者进行了单纯切除治疗。中位随访时间为58个月,4例患者出现同侧乳腺肿瘤复发(IBTR)。4例复发中有2例为浸润性,2例为DCIS。IBTR的5年发生率为6.1%。切缘<1.0 cm的患者IBTR发生率显著高于切缘≥1.0 cm的患者(5年时分别为23.1%和1.5%,p<0.01)。总之,对于单纯切除术后切缘<1.0 cm的患者,由于IBTR风险较高,放疗是必要的。

相似文献

1
Excision alone for small size ductal carcinoma in situ of the breast.单纯切除治疗小尺寸乳腺导管原位癌。
Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23.
2
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.保乳手术后原位导管癌与浸润性乳腺癌同侧乳腺肿瘤复发情况的比较。
World J Surg Oncol. 2016 Apr 27;14:126. doi: 10.1186/s12957-016-0885-6.
3
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.接受保乳治疗或乳房切除术的乳腺导管原位癌患者局部复发及特定病因生存率的相关因素。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11.
4
Prospective study of wide excision alone for ductal carcinoma in situ of the breast.单纯乳腺导管原位癌广泛切除的前瞻性研究
J Clin Oncol. 2006 Mar 1;24(7):1031-6. doi: 10.1200/JCO.2005.02.9975. Epub 2006 Feb 6.
5
Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.术前磁共振成像背景实质信号增强比:与保乳手术后乳腺原位癌患者局部复发的关系。
Radiology. 2014 Mar;270(3):699-707. doi: 10.1148/radiol.13130459. Epub 2013 Oct 28.
6
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.经乳房钼靶检查发现、临床隐匿的导管原位癌,采用保乳手术及根治性乳房放疗进行治疗。
Cancer J Sci Am. 1996 May-Jun;2(3):158-65.
7
Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.从 ASTRO 共识小组中移除导管原位癌(DCIS)是否应该谨慎?对 300 例接受加速部分乳腺照射(APBI)治疗的 DCIS 患者结局的汇总分析。
Ann Surg Oncol. 2013 Apr;20(4):1275-81. doi: 10.1245/s10434-012-2694-7. Epub 2012 Sep 29.
8
Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.导管原位癌——放疗增敏对局部控制的影响。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e153-8. doi: 10.1016/j.ijrobp.2011.03.045. Epub 2011 Jun 12.
9
Factors predicting in-breast tumor recurrence after breast-conserving surgery.保乳手术后乳腺肿瘤复发的预测因素。
Breast Cancer Res Treat. 2009 Jul;116(1):171-7. doi: 10.1007/s10549-008-0187-y. Epub 2008 Sep 25.
10
Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer?保乳手术后,更高的放射剂量对于获得切缘阳性是否必要?
Breast. 2019 Oct;47:16-21. doi: 10.1016/j.breast.2019.06.005. Epub 2019 Jun 25.

引用本文的文献

1
Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis.低危型导管原位癌的结局:系统评价和荟萃分析。
Breast Cancer Res Treat. 2024 Nov;208(2):237-251. doi: 10.1007/s10549-024-07473-w. Epub 2024 Aug 24.
2
The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.保乳治疗的导管原位癌女性患者手术切缘与局部复发的相关性:一项荟萃分析
Ann Surg Oncol. 2016 Nov;23(12):3811-3821. doi: 10.1245/s10434-016-5446-2. Epub 2016 Aug 15.
3
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
保乳手术后原位导管癌与浸润性乳腺癌同侧乳腺肿瘤复发情况的比较。
World J Surg Oncol. 2016 Apr 27;14:126. doi: 10.1186/s12957-016-0885-6.
4
Proportion and clinical outcomes of postoperative radiotherapy omission after breast-conserving surgery in women with breast cancer.保乳手术后乳腺癌女性术后放疗省略的比例和临床结局。
J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27.